Notice of Conclusion of License Agreement with Summit Pharmaceuticals International Corporation for the Manufacture and Sale of Artificial Modified Nucleic Acid Amidite 2024/12/17 Notice Read
The “Hello Tomorrow JAPAN Deep Tech Summit 2024” has selected our President and CEO, Mr. Hideaki Sato, as a finalist in [Japan Challenge 2024] 2024/12/05 Event Read
Result of the Ex-post evaluation of the Spinal Cord Injury (SCI) Program of Cyclic Innovation for Clinical Empowerment (CiCLE) supported by Japan Agency for Medical Research and Development (AMED) 2024/11/28 Notice Read
We will exhibit at the Organization for Small & Medium Enterprises and Regional Innovation, Japan booth at “Bio Japan 2024”. 2024/10/07 Event Read
We have been selected for the “Research and Development Program for Innovative Biologics” in 2024. 2024/09/12 Notice Read
